|16.88||-0.02 / -0.12%|
Data as of 3:59pm ET
|16.88||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 19.00, with a high estimate of 26.00 and a low estimate of 7.00. The median estimate represents a +12.56% increase from the last price of 16.88.
The current consensus among 3 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.